23 September, 2026

Taiwan
National Taiwan University Hospital inks MoU with Johnson & Johnson

To further enhance Taiwan’s role in global clinical research and innovative drug development, accelerate the advan...Read more

- 22 September 2026 News

Australia
Australia's Telix Pharma signs strategic agreement of $1.65 B to merge with ITM Isotope Technologies

Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Technologies Mu...Read more

- 22 September 2026 News


China
China's BoomRay Pharma enters license agreement worth $900 M with Novartis for novel radioligand therapy asset


Boomray Pharmaceuticals, a China-based clinical-stage biotechnology company pioneering innovative radioligand therapies ...Read more

- 22 September 2026 News


Korea
Korea's 1ST Biotherapeutics and SK Biopharma announce partnership for Parkinson's treatment


South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global li...Read more

- 22 September 2026 News



HER Health
DKSH launches Colpofix® to support cervical health in women with HPV in Singapore


Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infecti...Read more

- 22 September 2026 News





All you want to read on

North America Europe Asia Pacific
South East Asia SAARC Middle East



This email has been sent to you in association with
www.biospectrumasia.com
Tell Us What You Think! Help us improve our newsletters.
Send us your feedback!
© Copyright 2026 MM ACTIV. All rights reserved.
To Unsubscribe click here.

Disclaimer : Please remember – by opting-in you are still able to opt-out at any time, by simply replying to this email at digital@mmactiv.com and typing 'unsubscribe' in the 'subject' field of any future emails. We promise only to send emails that we believe you will find interesting, relevant and current.
Your data will never be sold or shared with any third party, although we may communicate a message to you from a partner that we are in collaboration with.